Novozymes and Chr. Hansen to combine


Disclaimer

DISCLAIMER - DOCUMENTS RELATED TO THE MERGER OF CHR. HANSEN HOLDING A/S AND NOVOZYMES A/S

DUE TO LEGAL RESTRICTIONS, THE INFORMATION ON THIS WEBSITE, WWW.CHR-HANSEN.COM/INVESTORS/PROPOSED-MERGER (THE “WEBSITE”), IS NOT DIRECTED TO, OR ACCESSIBLE FOR, CERTAIN PERSONS.

WE THEREFORE KINDLY ASK YOU TO REVIEW THIS NOTICE CAREFULLY EACH TIME YOU WISH TO BE GRANTED ACCESS TO THIS WEBSITE. THIS NOTICE APPLIES TO ALL VISITORS OF THIS WEBSITE.

DEPENDING ON WHO YOU ARE AND WHERE YOU LIVE, IT MAY AFFECT YOUR RIGHTS. PLEASE NOTE THAT THIS NOTICE AND THE INFORMATION CONTAINED IN IT MAY BE ALTERED OR UPDATED FROM TIME TO TIME. IN ADDITION, THE CONTENTS OF THIS WEBSITE MAY BE AMENDED AT ANY TIME IN WHOLE OR IN PART AT THE SOLE DISCRETION OF CHR. HANSEN HOLDING A/S ("CHR. HANSEN").

ACCESS TO THE MATERIALS CONTAINED ON THIS WEBSITE MAY BE RESTRICTED UNDER THE SECURITIES LAWS IN CERTAIN JURISDICTIONS. THIS NOTICE REQUIRES YOU TO CONFIRM CERTAIN MATTERS (INCLUDING THAT YOU ARE NOT RESIDENT IN SUCH JURISDICTION) BEFORE YOU MAY OBTAIN ACCESS TO THE INFORMATION ON THE WEBSITE. IF YOU ARE UNABLE, OR HAVE ANY DOUBT WHETHER YOU ARE ABLE, TO PROVIDE THE NECESSARY CONFIRMATION, THEN YOU SHOULD PRESS 'NO' AND YOU WILL NOT BE ABLE TO VIEW INFORMATION ON THE WEBSITE.

The information contained on this Website is not intended for, and must not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident or physically present in the United States of America (including its territories and possessions, any state of the United States and the District of Columbia, the "United States") (subject to certain exceptions), Canada, South Africa and Japan, or any jurisdiction where doing so might constitute a violation of the local securities laws or regulations of such jurisdiction. Further, the information contained on this Website does not constitute an offer to sell or the solicitation of an offer to buy or acquire, any shares or other securities of Chr. Hansen or Novozymes A/S (“Novozymes”).

None of the shares referred to on this Website (the "Shares") have been or will be registered under the U.S. Securities Act of 1933, as emended (the “Securities Act”) and may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There is no intention to register any Shares referred to herein in the United States or to make a public offering of Shares in the United States.

Access to the information and documents contained on the Website may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access such information and documents. All persons residing in jurisdictions other than Denmark and Australia who wish to have access to the documents contained on this Website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this Website, or require registration or approval for any acquisition of securities by them. No such registration or approval has been obtained outside of Denmark or Australia. Chr. Hansen assumes no responsibility if there is a violation of applicable law and regulations by any person.

The contents of this Website are not to be incorporated into, or construed to form part of, any of the documents included herein, unless specifically stated in such documents. Except as otherwise explicitly stated herein as applicable to them, no information included on this Website should be used by investors in forming their investment decision.

The use of this Website is subject to Danish law and any disputes arising out of or regarding this Website is subject to Danish law and the exclusive jurisdictions of the Danish courts.

I therefore certify that

  1. I am:
    • resident in Denmark; OR
    • resident in Australia; OR
    • a “qualified institutional buyer” in the United States as such term is defined in Rule 144A of the Securities Act; OR
    • an institutional investor neither located or resident in the United States, Canada, South Africa, Japan nor any jurisdiction in which it would be unlawful to access any prospectus, exemption document or other offer materials published by Chr. Hansen in connection with the proposed transaction.

AND

  1. I have read, understand and agree to comply with all of the restrictions set forth above in this notice.

Yes  No

 

Partager